List of Excipients in API LINACLOTIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing LINACLOTIDE
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Allergan Inc | LINZESS | linaclotide | 0456-1201 | CALCIUM CHLORIDE | |
Allergan Inc | LINZESS | linaclotide | 0456-1201 | CELLULOSE, MICROCRYSTALLINE | |
Allergan Inc | LINZESS | linaclotide | 0456-1201 | GELATIN | |
Allergan Inc | LINZESS | linaclotide | 0456-1201 | HYPROMELLOSE | |
Allergan Inc | LINZESS | linaclotide | 0456-1201 | LEUCINE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for LINACLOTIDE
Excipient focus: CALCIUM CHLORIDE
LINACLOTIDE drug variants containing CALCIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | linaclotide | 0456-1201 |
>Company | >Ingredient | >NDC |
LINACLOTIDE drug variants not containing CALCIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
LINACLOTIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | linaclotide | 0456-1201 |
>Company | >Ingredient | >NDC |
LINACLOTIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
LINACLOTIDE drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | linaclotide | 0456-1201 |
>Company | >Ingredient | >NDC |
LINACLOTIDE drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
LINACLOTIDE drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | linaclotide | 0456-1201 |
>Company | >Ingredient | >NDC |
LINACLOTIDE drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LEUCINE
LINACLOTIDE drug variants containing LEUCINE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | linaclotide | 0456-1201 |
>Company | >Ingredient | >NDC |
LINACLOTIDE drug variants not containing LEUCINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
LINACLOTIDE drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | linaclotide | 0456-1201 |
>Company | >Ingredient | >NDC |
LINACLOTIDE drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.